“Today, we will be taking a journey of collaboration together. You will be asked, and I hope that you will take the opportunity to share your thoughts on how MICHR can support you, your community, and your concerns and how you can support each other as we seek to advance and share our mission to improve the health and wellness of everyone in our state,” said Elder Sara Bailey, CEO of Bridges Into the Future and community representative on the MICHR cabinet, at the opening of the IDEAL-CTS MICHR mixer for community and academic partners in December 2023.
Stories of Impact
MICHR to tackle goal of diversifying and improving research to speed therapies for benefit of all patients
COVID-19, Stories of Impact
A new groundbreaking study from the University of Michigan’s Center for Drug Repurposing (CDR) reveals several drug contenders already in use for other purposes—including one dietary supplement—that have been shown to block or reduce SARS-CoV-2 infection in cells.
The study, published recently in the Proceedings of the National Academy of Sciences, uses artificial intelligence-powered image analysis of human cell lines during infection with the novel coronavirus.
MICHR Funding, Funding & Grant Writing
Are you interested in positioning your interdisciplinary research team to be competitive for an external large-scale grant (e.g., NIH U- and P-series mechanisms)? If so, you’re encouraged to apply for $100,000 in funding and tailored research support available through the Accelerating Synergy Award.
Regulatory Support (MIAP)
In an effort to make access to experimental agents easier and more efficient, Transforming Expanded Access to Maximize Support and Study (TEAMSS) has published new recommended guidelines, templates, and resources for physicians and institutions seeking Expanded Access for their patients.